EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Potential of Marine Sponge Metabolites against Prions: Bromotyrosine Derivatives, a Family of Interest

Maha Sinane, Colin Grunberger, Lucile Gentile iD, Céline Moriou iD, Victorien Chaker, Pierre Coutrot, Alain Guenneguez, Marie-Aude Poullaouec, Solène Connan iD, Valérie Stiger-Pouvreau iD, Mayalen Zubia, Yannick Fleury iD und 5 weitere

Marine Drugs · 2024

DOI: 10.3390/md22100456 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Marine Drugs, 2024. Verfasst von Maha Sinane und 16 weiteren Autor:innen. Beteiligte Einrichtung: Univ Brest, Inserm, EFS, UMR 1078, GGB, School of Medicine, F-29200 Brest, France. Hauptthemen laut MEDLINE: Porifera, Tyrosine, Prions. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Institut Universitaire Européen de la Mer - Univ Brest, Institut Brestois Santé Agro Matière - Univ Brest, Flotte Océanographique Française.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The screening of 166 extracts from tropical marine organisms (invertebrates, macroalgae) and 3 cyclolipopeptides from microorganisms against yeast prions highlighted the potential of Verongiida sponges to prevent the propagation of prions. We isolated the known compounds purealidin Q (1), aplysamine-2 (2), pseudoceratinine A (3), aerophobin-2 (4), aplysamine-1 (5), and pseudoceratinine B (6) for the first time from the Wallisian sponge Suberea laboutei. We then tested compounds 1–6 and sixteen other bromotyrosine and bromophenol derivatives previously isolated from Verongiida sponges against yeast prions, demonstrating the potential of 1–3, 5, 6, aplyzanzine C (7), purealidin A (10), psammaplysenes D (11) and F (12), anomoian F (14), and N,N-dimethyldibromotyramine (15). Following biological tests on mammalian cells, we report here the identification of the hitherto unknown ability of the six bromotyrosine derivatives 1, 2, 5, 7, 11, and 14 of marine origin to reduce the spread of the PrPSc prion and the ability of compounds 1 and 2 to reduce endoplasmic reticulum stress. These two biological activities of these bromotyrosine derivatives are, to our knowledge, described here for the first time, offering a new therapeutic perspective for patients suffering from prion diseases that are presently untreatable and consequently fatal.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PoriferaTyrosinePrionsAnimalsAquatic OrganismsHumansPrPSc ProteinsMice

Stichwörter der Autor:innen

ER stressPrPScSuberea labouteiVerongiidabromotyrosine derivativesmarine spongesprion diseasesyeast-based screening

Substanzen

TyrosinebromotyrosinePrionsPrPSc Proteins

Autor:innen und Institutionen

  • Univ Brest, Inserm, EFS, UMR 1078, GGB, School of Medicine, F-29200 Brest, France.
  • IRD, CNRS, Ifremer, Univ Brest, LEMAR, IUEM, F-29280 Plouzane, France.
  • CNRS, Institut de Chimie des Substances Naturelles, Université Paris-Saclay, F-91190 Gif-sur-Yvette, France.
  • UPF, Ifremer, ILM, IRD, UMR 241 SECOPOL, BP6570, 98702 Faa'a, Tahiti, French Polynesia.
  • Univ Brest, Univ Bretagne Sud, CNRS, LBCM, EMR 6076, F-29000 Quimper, France.
  • Univ Brest, Plateforme RMN-RPE, F-29238 Brest, France.

ORCID-Profile: Lucile Gentile, Céline Moriou, Solène Connan, Valérie Stiger-Pouvreau, Yannick Fleury, Ali Al-Mourabit, Sylvain Petek, Cécile Voisset

Förderung

  • Institut Universitaire Européen de la Mer - Univ Brest
  • Institut Brestois Santé Agro Matière - Univ Brest
  • Flotte Océanographique Française
  • Labex Mer
  • Inserm Grand Ouest
  • Institut de Recherche pour le Développement
  • Ministère de l'enseignement supérieur et de la recherche
  • Centre National de la Recherche Scientifique

Zitieren

APA

Sinane, M., Grunberger, C., Gentile, L., Moriou, C., Chaker, V., Coutrot, P., Guenneguez, A., Poullaouec, M. A., Connan, S., Stiger-Pouvreau, V., Zubia, M., Fleury, Y., Cérantola, S., Kervarec, N., Al-Mourabit, A., Petek, S., & Voisset, C. (2024). Potential of Marine Sponge Metabolites against Prions: Bromotyrosine Derivatives, a Family of Interest. Marine Drugs. https://doi.org/10.3390/md22100456

Vancouver

Sinane M, Grunberger C, Gentile L, Moriou C, Chaker V, Coutrot P, et al. Potential of Marine Sponge Metabolites against Prions: Bromotyrosine Derivatives, a Family of Interest. Marine Drugs. 2024. doi:10.3390/md22100456

BibTeX
@article{Sinane2024,
  author = {Sinane, Maha and Grunberger, Colin and Gentile, Lucile and Moriou, Céline and Chaker, Victorien and Coutrot, Pierre and Guenneguez, Alain and Poullaouec, Marie-Aude and Connan, Solène and Stiger-Pouvreau, Valérie and Zubia, Mayalen and Fleury, Yannick and Cérantola, Stéphane and Kervarec, Nelly and Al-Mourabit, Ali and Petek, Sylvain and Voisset, Cécile},
  title = {Potential of Marine Sponge Metabolites against Prions: Bromotyrosine Derivatives, a Family of Interest},
  journal = {Marine Drugs},
  year = {2024},
  doi = {10.3390/md22100456}
}
Kostenlos starten →